Mikito Hirakata
Kamakura, 2488555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TXB-001, A Newly-Developed Polymer-Conjugated Anthracycline, Alleviates Anthracycline-Induced Cardiotoxicity.
Journal: Cardiovascular toxicology
Published: October 18, 2024
TXB-001, a newly-developed polymer-conjugated anthracycline: Significantly lower adverse effects in animal models of alopecia and hand-foot syndrome.
Journal: Toxicology and applied pharmacology
Published: December 12, 2023
Pregabalin Prescription for Neuropathic Pain and Fibromyalgia: A Descriptive Study Using Administrative Database in Japan.
Journal: Pain research & management
Published: November 15, 2017
Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex.
Journal: International urology and nephrology
Published: November 25, 2016
Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases.
Journal: Scandinavian journal of rheumatology
Published: August 28, 2015
Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys.
Journal: Journal of pharmacological sciences
Published: June 15, 2015
Evaluation of the repeated-dose liver micronucleus assay using 2,4-dinitrotoluene: a report of a collaborative study by CSGMT/JEMS.MMS.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: June 13, 2015
Characteristics of TRK-130 (Naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive bladder.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 15, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026